Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Other Operating Expenses (2019 - 2020)

Historic Other Operating Expenses for Korro Bio (KRRO) over the last 2 years, with Q4 2020 value amounting to -$11.8 million.

  • Korro Bio's Other Operating Expenses fell 12655.26% to -$11.8 million in Q4 2020 from the same period last year, while for Sep 2021 it was -$11.8 million, marking a year-over-year decrease of 12655.26%. This contributed to the annual value of -$16.9 million for FY2019, which is N/A changed from last year.
  • Per Korro Bio's latest filing, its Other Operating Expenses stood at -$11.8 million for Q4 2020, which was down 12655.26% from -$5.2 million recorded in Q4 2019.
  • In the past 5 years, Korro Bio's Other Operating Expenses ranged from a high of -$4.5 million in Q3 2019 and a low of -$11.8 million during Q4 2020